adipose-derived mesenchymal stem cell therapy (Instituto de Terapia Celular)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameadipose-derived mesenchymal stem cell therapy (Instituto de Terapia Celular)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMexico
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInstituto de Terapia Celular
China Registration ClassN/A

Develop Information

Active CompaniesInstituto de Terapia Celular
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A